Each region collaborates with clinical sites to identify and define key variables, harmonize and effectively analyze the data to generate large datasets. These data can be merged across regions to address research questions related to the impact of the global ART rollout on HIV-related clinical outcomes.

Read the IeDEA brochure

The 17th International Conference on Malignancies in HIV/AIDS will take place in Bethesda, Maryland from October 21 to 22, 2019

17th International Conference on
Malignancies in HIV/AIDS

EACS 2019

The 17th European AIDS Conference will take place in Basel, Switzerland from November 6-9, 2019

Visit the EACS 2019 website

1st December 2019

World AIDS Day

Visit the
World AIDS Day website

The 20th ICASA conference will be held in Kigali, Rwanda from 2 - 7 December.

ICASA 2019

Register now!

Abstract submissions and scholarship applications for CROI 2020 now open!

CROI 2020

For more information visit the
CROI 2020 website

Submission deadline: September 26

IWHOD 2020

The International Workshop on HIV and Hepatitis Observational Databases (IWHOD) brings senior and junior HIV and hepatitis observational database researchers together to advance the methodology and analysis of observational data.

Visit the IWHOD 2020 website

Who We Are

IeDEA is an international research consortium established in 2006 by the National Institute of Allergy and Infectious Diseases to provide a rich resource for globally diverse HIV/AIDS data.

The IeDEA Cohort Consortium collaborates to collect and define key variables, harmonize data, and implement methodology to effectively pool data as a cost-effective means of generating large data sets to address the high priority research questions and streamline HIV/AIDS research.

IeDEA collects HIV/AIDS data from seven international regional data centers, including four in Africa, and one each in the Asia-Pacific region, the Central/South America/Caribbean region, and North America. These regional data centers consolidate, curate and analyze data on care and treatment of HIV to evaluate the outcomes of people living with HIV/AIDS.

Continue reading